Billy Kelleher
Question:1017. Deputy Billy Kelleher asked the Minister for Health if the Health Service Executive will include Thyrogen in the National Cancer Control Programme; and if he will make a statement on the matter. [33938/14]
View answerWednesday, 17 September 2014
Questions (1017)
Written answers
Two care options are available for the preparation of patients who are diagnosed with thyroid cancer for radio-active iodine ablation - either withdrawal of oral thyroxine treatment or treatment with Thyrogen®. Both options are in line with international guidelines.
The treatment option utilised is determined by the prescribing consultant and the hospital’s Drugs and Therapeutics Committee.